Literature DB >> 28034980

Patients with Concomitant Chronic Neck Pain and Myofascial Pain in Masticatory Muscles Have More Widespread Pain and Distal Hyperalgesia than Patients with Only Chronic Neck Pain.

Daniel Muñoz-García1,2, Ibai López-de-Uralde-Villanueva1,2,3,4, Héctor Beltrán-Alacreu1,2,3, Roy La Touche1,2,3,4, Josué Fernández-Carnero2,3,4,5.   

Abstract

Objective: Insufficient evidence exists to compare widespread pain (WP), pain sensibility, and psychological factors that occur in patients presenting with chronic neck pain (CNP) or a combination of temporomandibular disorder (TMD) and other complaints. The present study compared the pain sensibility and psychological factors of subjects with CNP with those with TMD + CNP. Design: Cross-sectional study. Setting: Local community. Subjects: A nonprobabilistic convenience sample of 86 persons with CNP or TMD was recruited into three groups: CNP, TMD with myofascial pain in masticatory muscles with cocomitant CNP (TMD + CNP), and asymptomatic control groups consisted of 27, 29, and 30 participants, respectively.
Methods: Participants underwent a clinical examination to evaluate WP with computerized assessment based on the pain drawing, pressure pain thresholds (PPT), and psychological factors, which were evaluated using the pain catastrophizing scale (PCS) and the state-trait anxiety inventory (STAI).
Results: Statistically significant differences were observed between participants with CNP and TMD + CNP for WP (t = -2.80, P  < 0.01, d = -1.06). Post hoc analyses only revealed significant differences between TMD + CNP participants and asymptomatic controls for PPT at extratrigeminal areas. Pearson correlation analyses showed a moderate positive association between symptomatic groups within the WP and STAI ( P  < 0.05) and a moderate negative association between PCS and PPT ( P  < 0.05) at the right tibialis muscle.
Conclusion: TMD + CNP participants had more areas of pain and also showed widespread pain hyperalgesia. Both groups of participants had psychological factors positively associated with STAI and WP; further, PCS and the PPT at the extratrigeminal region were negatively associated with each other in both groups, except for the left tibialis in the TMD + CNP group.
© 2016 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Anxiety; Neck Pain; Orofacial Pain; Pain Catastrophizing; Widespread Pain

Mesh:

Year:  2017        PMID: 28034980     DOI: 10.1093/pm/pnw274

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  5 in total

Review 1.  Chronic orofacial pain.

Authors:  Sowmya Ananthan; Rafael Benoliel
Journal:  J Neural Transm (Vienna)       Date:  2020-03-04       Impact factor: 3.575

2.  Contextual modulation of pain sensitivity utilising virtual environments.

Authors:  Ashley Smith; Klancy Carlow; Tara Biddulph; Brooke Murray; Melissa Paton; Daniel S Harvie
Journal:  Br J Pain       Date:  2017-03-15

3.  Local and Widespread Pressure Pain Hyperalgesia Is Not Side Specific in Females with Unilateral Neck Pain that Can Be Reproduced during Passive Neck Rotation.

Authors:  Fernando Piña-Pozo; Alberto Marcos Heredia-Rizo; Pascal Madeleine; Isabel Escobio-Prieto; Antonio Luque-Carrasco; Ángel Oliva-Pascual-Vaca
Journal:  J Clin Med       Date:  2019-08-18       Impact factor: 4.241

4.  Profiling and Association over Time between Disability and Pain Features in Patients with Chronic Nonspecific Neck Pain: A Longitudinal Study.

Authors:  Gorka Ortego; Enrique Lluch; Pablo Herrero; Shellie Ann Boudreau; Victor Doménech-García
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

5.  Relationship between healthcare seeking and pain expansion in patients with nonspecific chronic low back pain.

Authors:  Mónica Grande-Alonso; Daniel Muñoz-García; Ferran Cuenca-Martínez; Laura Delgado-Sanz; María Prieto-Aldana; Roy La Touche; Alfonso Gil-Martínez
Journal:  PeerJ       Date:  2020-03-09       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.